Glyriva bexicap - 50 mcg

Capsule

Pack Size : 10 Capsule x 1 Stips

Generics : Glycopyrronium Bromide

Manufacturer : Beximco Pharmaceuticals Ltd.

Best Price * TK 200.00

* Delivery will be done in Dhaka city only.

Alternative Product

More Information About - Glyriva bexicap - 50 mcg

Description

Generic Name

Glycopyrronium bromide (Glycopyrrolate) Inhalation

Precaution

Glycopyrronium should not be used for the initial treatment of acute episodes of bronchospasm, i.e. rescue therapy. Immediate hypersensitivity reactions may occur after administration of Glycopyrronium inhalation powder. As with other anticholinergic drugs, Glycopyrronium should be used with caution in patients with narrow-angle glaucoma, prostatic hyperplasia or bladder-neck obstruction.

Indication

Maintenance bronchodilator treatment to relieve symptoms in adult patients with, chronic obstructive pulmonary disease (COPD).

Contra Indication

Hypersensitivity to the active substance or to any of the excipients.

Dose

N/A

Side Effect

Inhaled medicines may cause inhalation-induced bronchospasm, dehydration, dry mouth, constipation, dizziness, insomnia, skin and subcutaneous tissue disorders, immune system disorders.

Pregnancy Category

Name : Not Classified

Description

FDA has not yet classified the drug into a specified pregnancy category.

Mode of Action

Glycopyrronium is a long-acting, specific antimuscarinic agent, in clinical medicine often called an anticholinergic. It has a similar affinity to the subtypes of muscarinic receptors M1 to M5. In the airways, inhibition of M3-receptors at the smooth muscle results in relaxation.

Interaction

N/A

Pregnancy Category Note

Pregnancy There are no adequate and well-controlled studies in humans Animal studies have not shown teratogenicity Lactation Unknown if distributed in human breast milk Consider the developmental and health benefits of breastfeeding along with the mother?s clinical need for the drug, and any potential adverse effects on the breastfed infant from the drug or from the underlying maternal condition

Adult Dose

Inhalation The recommended dosage of Glycopyrronium inhalation: One capsule once daily with the ConviHaler device at the same time of day.

Child Dose

N/A

Renal Dose

N/A

Administration

N/A

Disclaimer

The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.